Sectors
Moderna raises USD110 million to develop messenger RNA Therapeutics
US-based pharmaceutical company Moderna Therapeutics announced its completion of a new funding round worth USD110 million for the development of its messenger ribonucleic (RNA) Therapeutics.
New York comptroller faces uphill battle to reduce management fees of pension funds- report
Incoming New York comptroller Scott Stringer will be faced with the challenge of bringing down the management fees paid by the city's five pension funds when he assumes office in January, a Bloomberg report said.
Vena inks deal to sell Uranium assets to Azincourt Uranium
Vena Resources Inc agreed to sell its 50% stake in Minergia SAC, the company's joint venture with Cameco Global Exploration Ltd, to Azincourt Uranium Inc.
Opponents of Empire State IPO asks appeals court to declare buyout provision illegal
Investors who had opposed the initial public offering of the Empire State Building asked a Manhattan appeals court to rule a USD 100 per unit buyout provision in the IPO plan illegal.